Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis

Kidney Int. 2015 Nov;88(5):1070-8. doi: 10.1038/ki.2015.181. Epub 2015 Jul 1.

Abstract

Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) is a recently discovered rare disease caused by gain-of-function mutations of the V2 vasopressin receptor gene, AVPR2. To date, mutations of Phe229 and Arg137 have been identified as gain-of-function in the V2 vasopressin receptor (V2R). These receptor mutations lead to hyponatremia, which may lead to clinical symptoms in infants. Here we present a newly identified I130N substitution in exon 2 of the V2R gene in a family, causing NSIAD. This I130N mutation resulted in constitutive activity of the V2R with constitutive cyclic adenosine monophosphate (cAMP) generation in HEK293 cells. This basal activity could be blocked by the inverse agonist tolvaptan and arginine-vasopressin stimulation enhanced the cAMP production of I130N-V2R. The mutation causes a biased receptor conformation as the basal cAMP generation activity of I130N does not lead to interaction with β-arrestin. The constitutive activity of the mutant receptor caused constitutive dynamin-dependent and β-arrestin-independent internalization. The inhibition of basal internalization using dominant-negative dynamin resulted in an increased cell surface expression. In contrast to the constitutive internalization, agonist-induced endocytosis was β-arrestin dependent. Thus, tolvaptan could be used for treatment of hyponatremia in patients with NSIAD who carry the I130N-V2R mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antidiuretic Hormone Receptor Antagonists / pharmacology
  • Arrestins / metabolism
  • Benzazepines / pharmacology
  • Cell Membrane / chemistry
  • Cyclic AMP / biosynthesis*
  • DNA Mutational Analysis
  • Dynamins / metabolism
  • Endocytosis / drug effects
  • Exons
  • Female
  • Genetic Diseases, X-Linked / genetics*
  • HEK293 Cells
  • Humans
  • Hyponatremia / drug therapy
  • Hyponatremia / genetics*
  • Inappropriate ADH Syndrome / genetics*
  • Male
  • Mutation
  • Pedigree
  • Receptors, Vasopressin / analysis
  • Receptors, Vasopressin / genetics*
  • Receptors, Vasopressin / metabolism
  • Tolvaptan
  • beta-Arrestins

Substances

  • AVPR2 protein, human
  • Antidiuretic Hormone Receptor Antagonists
  • Arrestins
  • Benzazepines
  • Receptors, Vasopressin
  • beta-Arrestins
  • Tolvaptan
  • Cyclic AMP
  • Dynamins

Supplementary concepts

  • Nephrogenic Syndrome of Inappropriate Antidiuresis